[1] La Torre JAD, Vilagut G, Ronaldson A, et al. Prevalence and variability of current depressive disorder in 27 European countries: a population-based study. Lancet Public Health, 2021; 6, e729−38. doi:  10.1016/S2468-2667(21)00047-5
[2] GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, 2018; 392, 1789−858. doi:  10.1016/S0140-6736(18)32279-7
[3] Malhi GS, Mann JJ. Depression. Lancet, 2018; 392, 2299−312. doi:  10.1016/S0140-6736(18)31948-2
[4] Herrman H, Patel V, Kieling C, et al. Time for united action on depression: a Lancet-World Psychiatric Association Commission. Lancet, 2022; 399, 957−1022. doi:  10.1016/S0140-6736(21)02141-3
[5] Gold SM, Köhler-Forsberg O, Moss-Morris R, et al. Comorbid depression in medical diseases. Nat Rev Dis Primers, 2020; 6, 69. doi:  10.1038/s41572-020-0200-2
[6] White J, Zaninotto P, Walters K, et al. Severity of depressive symptoms as a predictor of mortality: the English longitudinal study of ageing. Psychol Med, 2015; 45, 2771−9. doi:  10.1017/S0033291715000732
[7] Rubin R. Exploring the relationship between depression and dementia. JAMA, 2018; 320, 961−2. doi:  10.1001/jama.2018.11154
[8] Harshfield EL, Pennells L, Schwartz JE, et al. Association between depressive symptoms and incident cardiovascular diseases. JAMA, 2020; 324, 2396−405. doi:  10.1001/jama.2020.23068
[9] O'Brien EC, Greiner MA, Sims M, et al. Depressive symptoms and risk of cardiovascular events in blacks: findings from the Jackson heart study. Circ Cardiovasc Qual Outc, 2015; 8, 552−9.
[10] Joynt KE, Whellan DJ, O'Connor CM. Depression and cardiovascular disease: mechanisms of interaction. Biol Psychiatry, 2003; 54, 248−61. doi:  10.1016/S0006-3223(03)00568-7
[11] Nabi H, Chastang JF, Lefèvre T, et al. Trajectories of depressive episodes and hypertension over 24 years: the Whitehall II prospective cohort study. Hypertension, 2011; 57, 710−6. doi:  10.1161/HYPERTENSIONAHA.110.164061
[12] Zheng FF, Zhong BL, Song XY, et al. Persistent depressive symptoms and cognitive decline in older adults. Brit J Psychiat, 2018; 213, 638−44. doi:  10.1192/bjp.2018.155
[13] Zhu YD, Li CL, Wu T, et al. Associations of cumulative depressive symptoms with subsequent cognitive decline and adverse health events: two prospective cohort studies. J Affect Disord, 2023; 320, 91−7. doi:  10.1016/j.jad.2022.09.128
[14] Han LY, Shen SW, Wu Y, et al. Trajectories of depressive symptoms and risk of cardiovascular disease: evidence from the China health and retirement longitudinal study. J Psychiatr Res, 2022; 145, 137−43. doi:  10.1016/j.jpsychires.2021.12.017
[15] Cui YM, Zhu CS, Lian ZW, et al. Prospective association between depressive symptoms and stroke risk among middle-aged and older Chinese. BMC Psychiat, 2021; 21, 532. doi:  10.1186/s12888-021-03492-9
[16] Chen H, Zhou TJ, Wu SW, et al. Long-term variability in physiological measures in relation to mortality and epigenetic aging: prospective studies in the USA and China. BMC Med, 2023; 21, 20. doi:  10.1186/s12916-022-02674-w
[17] Hu JY, Zheng XY, Shi GDJ, et al. Associations of multiple chronic disease and depressive symptoms with incident stroke among Chinese middle-aged and elderly adults: a nationwide population-based cohort study. BMC Geriatr, 2022; 22, 660. doi:  10.1186/s12877-022-03329-4
[18] Sonnega A, Faul JD, Ofstedal MB, et al. Cohort profile: the Health and Retirement Study (HRS). Int J Epidemiol, 2014; 43, 576−85. doi:  10.1093/ije/dyu067
[19] Chen HJ, Mui AC. Factorial validity of the center for epidemiologic studies depression scale short form in older population in China. Int Psychogeriatr, 2014; 26, 49−57. doi:  10.1017/S1041610213001701
[20] Dang L, Dong LM, Mezuk B. Shades of blue and gray: a comparison of the center for epidemiologic studies depression scale and the composite international diagnostic interview for assessment of depression syndrome in later life. Gerontologist, 2020; 60, e242−53. doi:  10.1093/geront/gnz044
[21] Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas, 1977; 1, 385−401. doi:  10.1177/014662167700100306
[22] Jenkins LM, Garner CR, Kurian S, et al. Cumulative blood pressure exposure, basal ganglia, and thalamic morphology in midlife. Hypertension, 2020; 75, 1289−95. doi:  10.1161/HYPERTENSIONAHA.120.14678
[23] Al Hazzouri AZ, Vittinghoff E, Byers A, et al. Long-term cumulative depressive symptom burden and risk of cognitive decline and dementia among very old women. J Gerontol Ser A, 2014; 69, 595−601. doi:  10.1093/gerona/glt139
[24] Gao K, Cao LF, Ma WZ, et al. Association between sarcopenia and cardiovascular disease among middle-aged and older adults: findings from the China health and retirement longitudinal study. eClinicalMedicine, 2022; 44, 101264. doi:  10.1016/j.eclinm.2021.101264
[25] Liu Y, Ning N, Sun T, et al. Association between solid fuel use and nonfatal cardiovascular disease among middle-aged and older adults: findings from the China Health and Retirement Longitudinal Study (CHARLS). Sci Total Environ, 2023; 856, 159035. doi:  10.1016/j.scitotenv.2022.159035
[26] Li CL, Zhu YD, Ma YJ, et al. Association of cumulative blood pressure with cognitive decline, dementia, and mortality. J Am Coll Cardiol, 2022; 79, 1321−35.
[27] Yano Y, Reis JP, Levine DA, et al. Visit-to-visit blood pressure variability in young adulthood and hippocampal volume and integrity at middle age: the CARDIA study (Coronary Artery Risk Development in Young Adults). Hypertension, 2017; 70, 1091−8. doi:  10.1161/HYPERTENSIONAHA.117.10144
[28] Li HB, Zheng DQ, Li ZW, et al. Association of depressive symptoms with incident cardiovascular diseases in middle-aged and older Chinese adults. JAMA Netw Open, 2019; 2, e1916591. doi:  10.1001/jamanetworkopen.2019.16591
[29] Meng RW, Yu CQ, Liu N, et al. Association of depression with all-cause and cardiovascular disease mortality among adults in China. JAMA Netw Open, 2020; 3, e1921043. doi:  10.1001/jamanetworkopen.2019.21043
[30] Lee SY, Lee JP, Lee J, et al. Association between depressive symptoms and the risk of all-cause and cardiovascular mortality among US adults. Prog Neuro-Psychopharmacol Biol Psychiatry, 2023; 125, 110755. doi:  10.1016/j.pnpbp.2023.110755
[31] El Baou C, Desai R, Cooper C, et al. Psychological therapies for depression and cardiovascular risk: evidence from national healthcare records in England. Eur Heart J, 2023; 44, 1650−62. doi:  10.1093/eurheartj/ehad188
[32] Piantella S, Dragano N, Marques M, et al. Prospective increases in depression symptoms and markers of inflammation increase coronary heart disease risk - the Whitehall II cohort study. J Psychosom Res, 2021; 151, 110657. doi:  10.1016/j.jpsychores.2021.110657
[33] Wang YL, Jiang GG, Wang LP, et al. Association of the depressive scores, depressive symptoms, and conversion patterns of depressive symptoms with the risk of new-onset chronic diseases and multimorbidity in the middle-aged and elderly Chinese population. eClinicalMedicine, 2022; 52, 101603. doi:  10.1016/j.eclinm.2022.101603
[34] Wu T, Li CL, Zhu YD, et al. The trajectories of depressive symptoms and subsequent incident dementia, coronary heart diseases, stroke and all-cause mortality. J Affect Disord, 2022; 312, 9−16. doi:  10.1016/j.jad.2022.06.001
[35] Moise N, Khodneva Y, Richman J, et al. Elucidating the association between depressive symptoms, coronary heart disease, and stroke in black and white adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. J Am Heart Assoc, 2016; 5, e003767. doi:  10.1161/JAHA.116.003767
[36] Sun J, Ma HX, Yu CQ, et al. Association of major depressive episodes with stroke risk in a prospective study of 0.5 million Chinese adults. Stroke, 2016; 47, 2203−8. doi:  10.1161/STROKEAHA.116.013512
[37] Dhar AK, Barton DA. Depression and the link with cardiovascular disease. Front Psychiatry, 2016; 7, 33.
[38] Jokinen J, Nordström P. HPA axis hyperactivity and cardiovascular mortality in mood disorder inpatients. J Affect Disord, 2009; 116, 88−92. doi:  10.1016/j.jad.2008.10.025
[39] Ladwig KH, Marten-Mittag B, Löwel H, et al. C-reactive protein, depressed mood, and the prediction of coronary heart disease in initially healthy men: results from the MONICA-KORA Augsburg Cohort Study 1984-1998. Eur Heart J, 2005; 26, 2537−42. doi:  10.1093/eurheartj/ehi456
[40] Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol, 2016; 16, 22−34. doi:  10.1038/nri.2015.5
[41] Williams MS, Rogers HL, Wang NY, et al. Do platelet-derived microparticles play a role in depression, inflammation, and acute coronary syndrome?. Psychosomatics, 2014; 55, 252−60. doi:  10.1016/j.psym.2013.09.004
[42] St-Onge MP, Zuraikat FM. Reciprocal roles of sleep and diet in cardiovascular health: a review of recent evidence and a potential mechanism. Curr Atheroscler Rep, 2019; 21, 11. doi:  10.1007/s11883-019-0772-z
[43] Corrigendum to: depression and coronary heart disease: 2018 position paper of the ESC working group on coronary pathophysiology and microcirculation developed under the auspices of the ESC Committee for Practice Guidelines. Eur Heart J, 2020; 41, 1696.
[44] Haapakoski R, Mathieu J, Ebmeier KP, et al. Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder. Brain Behav Immun, 2015; 49, 206−15. doi:  10.1016/j.bbi.2015.06.001
[45] Budhiraja R, Roth T, Hudgel DW, et al. Prevalence and polysomnographic correlates of insomnia comorbid with medical disorders. Sleep, 2011; 34, 859−67. doi:  10.5665/SLEEP.1114
[46] Laugsand LE, Vatten LJ, Platou C, et al. Insomnia and the risk of acute myocardial infarction: a population study. Circulation, 2011; 124, 2073−81. doi:  10.1161/CIRCULATIONAHA.111.025858
[47] Jha MK, Qamar A, Vaduganathan M, et al. Screening and management of depression in patients with cardiovascular disease: JACC state-of-the-art review. J Am Coll Cardiol, 2019; 73, 1827−45.
[48] Carney RM, Blumenthal JA, Freedland KE, et al. Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study. Psychosom Med, 2004; 66, 466−74. doi:  10.1097/01.psy.0000133362.75075.a6
[49] Ferrari AJ, Somerville AJ, Baxter AJ, et al. Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature. Psychol Med, 2013; 43, 471−81. doi:  10.1017/S0033291712001511